These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11000452)

  • 1. New approaches in vaccine development, 1999 (NAVD'99, 15-18 may, 1999, Vienna, Austria) and new approaches to bacterial vaccine development (NABVD'99, 19-22 may 1999, Munich, Germany).
    Lubitz W; von Specht B
    J Biotechnol; 2000 Sep; 83(1-2):1-2. PubMed ID: 11000452
    [No Abstract]   [Full Text] [Related]  

  • 2. Biotechnology of vaccine development.
    Liew FY
    Biotechnol Genet Eng Rev; 1990; 8():53-95. PubMed ID: 2094275
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular approaches for safer and stronger vaccines.
    Del Giudice G; Rappuoli R
    Schweiz Med Wochenschr; 1999 Nov; 129(46):1744-8. PubMed ID: 10603647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Approaches to Vaccine Development. Proceedings of a symposium. Vienna, Austria, 11-14 April 1995.
    J Biotechnol; 1996 Jan; 44(1-3):xi-xiii, 1-250. PubMed ID: 8829379
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings of the 4th International Meeting on New Approaches to Bacterial Vaccine Development. Munich, Germany, 27-29 May 2002.
    FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):85-200. PubMed ID: 12832110
    [No Abstract]   [Full Text] [Related]  

  • 6. New approaches to bacterial vaccine development. Proceedings of the 3rd International Meeting. Munich, Germany, 19-22 May 1999.
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):iii, 275-364. PubMed ID: 10809561
    [No Abstract]   [Full Text] [Related]  

  • 7. Bacterial infectious disease control by vaccine development.
    Curtiss R
    J Clin Invest; 2002 Oct; 110(8):1061-6. PubMed ID: 12393839
    [No Abstract]   [Full Text] [Related]  

  • 8. What biotechnology has to offer vaccine development.
    Fields BN; Chanock RM
    Rev Infect Dis; 1989; 11 Suppl 3():S519-23. PubMed ID: 2669095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New approaches to vaccine development.
    Doblander K; Lubitz W
    J Biotechnol; 1996 Jan; 44(1-3):xi-xiii. PubMed ID: 8717378
    [No Abstract]   [Full Text] [Related]  

  • 10. New ways to identify novel bacterial antigens for vaccine development.
    Movahedi AR; Hampson DJ
    Vet Microbiol; 2008 Sep; 131(1-2):1-13. PubMed ID: 18372122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress towards a vaccine against enterotoxigenic Escherichia coli.
    Kaper JB; Levine MM
    Vaccine; 1988 Apr; 6(2):197-9. PubMed ID: 2898844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards new leprosy and tuberculosis vaccines.
    Kaufmann S
    Microbiol Sci; 1987 Nov; 4(11):324-8. PubMed ID: 3155274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assuring the quality and safety of vaccines: regulatory licensing and batch release.
    Griffiths E; Knezevic I
    Methods Mol Med; 2003; 87():353-76. PubMed ID: 12958467
    [No Abstract]   [Full Text] [Related]  

  • 14. Vienna Vaccine Safety Initiative.
    Rath B
    Hum Vaccin Immunother; 2018 May; 14(5):1038-1041. PubMed ID: 29206079
    [No Abstract]   [Full Text] [Related]  

  • 15. Recombinant vaccines.
    Barnard RT
    Expert Rev Vaccines; 2010 May; 9(5):461-3. PubMed ID: 20450319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Trends in the studies of the preparations of active and passive immunization. Bacterial vaccines].
    Gałazka A
    Przegl Epidemiol; 1988; 42(4):317-31. PubMed ID: 3247475
    [No Abstract]   [Full Text] [Related]  

  • 17. Transgenic plants as vaccine production systems.
    Mason HS; Arntzen CJ
    Trends Biotechnol; 1995 Sep; 13(9):388-92. PubMed ID: 7546570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contemporary vaccinology--scientific and practical aspects].
    Piotrowska-Jastrzebska J; Mikołuć B; Motkowski R
    Pol Merkur Lekarski; 2002 Jun; 12(72):526-9. PubMed ID: 12362676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reverse vaccinology in the 21st century: improvements over the original design.
    Donati C; Rappuoli R
    Ann N Y Acad Sci; 2013 May; 1285():115-32. PubMed ID: 23527566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral bacterial vaccine vectors for the delivery of subunit and nucleic acid vaccines to the organized lymphoid tissue of the intestine.
    Pascual DW; Powell RJ; Lewis GK; Hone DM
    Behring Inst Mitt; 1997 Feb; (98):143-52. PubMed ID: 9382735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.